What should you look for in a Mounjaro doctor in New Cairo?
If you are looking for the best Mounjaro doctor in New Cairo, do not rely on a title or star rating alone. Turn the search into things you can verify: a physician who reviews your whole case, a decision based on benefits and risks, a food and activity plan, clear side-effect instructions, and continuing follow-up rather than a pen prescription on its own. You can start with an assessment by Dr Shimaa Fouad, a physician, clinical and therapeutic nutrition specialist, and ESPEN member, at La Rose Fifth Settlement in CMC Medical Mall, fourth floor, North 90th Street, behind the Air Force Specialized Hospital. The clinic runs on Wednesday from 3:30 to 8 pm.
The visit is not a promise of a prescription. Its purpose is to decide whether tirzepatide is suitable at all, whether the product being discussed is registered for the intended use, and what risks or alternatives apply. Under the current US labels, Mounjaro is indicated to improve glucose control in type 2 diabetes, while tirzepatide for weight management is marketed there as Zepbound. The clinician therefore has to base the decision on the locally registered product, your circumstances and a prescription, not a trend or somebody else's experience [1, 2, 3].
This guide is about choosing a Mounjaro doctor in Fifth Settlement and New Cairo: what to ask, what should happen at the first visit, and how to follow up between Wednesday visits. For the broad service, starting and switching overview, see Mounjaro and Wegovy in Fifth Settlement [1, 5].
Eight signs of responsible Mounjaro care
The first sign is that the decision belongs to a qualified physician who can review diagnoses, conditions and medicines and can say treatment is unsuitable when risk outweighs benefit. Second, the assessment does not stop at BMI; it considers waist, blood pressure, glucose, weight-related conditions, previous attempts, sleep, activity and eating pattern. Third, tests are ordered to answer a clinical question rather than sold as the same package to everyone. Fourth, you leave with a measurable health goal rather than a guaranteed weight number [3, 4, 5, 6].
Fifth, there is a nutrition plan alongside medicine. Lower appetite can reduce quantity, but it does not ensure adequate protein, fluid or nutrients. Sixth, follow-up measures more than scale weight: symptoms, ability to eat and drink, glucose when relevant, waist, function and body composition when useful. Seventh, before starting you know whom to contact for symptoms and which problems can wait for review versus needing faster action [10, 13, 14].
Eighth, there is a plan for slow response, poor tolerability, and a later discussion about continuing or stopping. A responsible clinician does not guarantee a particular loss, change treatment because of one quiet week on the scale, or sell an unknown product. Ask clearly: “What will we monitor, when will we reassess, and what is the maintenance plan from the beginning?” Safe programmes explain limits and long-term follow-up rather than making speed the whole decision [4, 5, 11].
Who may discuss tirzepatide, and who may need another route?
Tirzepatide for weight management is not intended for rapid cosmetic loss or an approaching event. A common official starting point for adults is a BMI of 30 or above, or 27 or above with a weight-related health condition, but that number is not a prescription. The clinician relates it to waist, glucose, blood pressure and lipids, the effect of weight on movement and sleep, medicines and previous treatment attempts. The visit may result in food and activity support without medicine, treatment of another cause, or coordination with another specialty [1, 3, 5, 6].
Contraindications and warnings must be reviewed before any decision. The tirzepatide weight-management label contraindicates use with a personal or family history of medullary thyroid carcinoma or MEN 2, or a previous serious hypersensitivity reaction to the ingredient. Pregnancy is not a time to use treatment whose purpose is weight loss. Symptoms of severely delayed stomach emptying, pancreatic or gallbladder history, repeated dehydration, kidney disease, diabetic retinopathy, or use of insulin and certain glucose-lowering medicines also need closer review. They are not all absolute exclusions, but each can change the plan and monitoring [1, 2, 14].
If your main question is who can take weight-loss injections, the dedicated article explains eligibility and exclusions without turning a list into self-diagnosis. The choosing standard here is a clinician who asks about the whole picture, explains alternatives, and does not encourage you to start, stop or switch treatment yourself [3, 5].
The first Mounjaro visit in Fifth Settlement: what should you bring?
Prepare a list of every medicine and supplement, recent tests and reports, and a short history of weight and previous attempts. Tell the clinician about diabetes, blood pressure, kidney, liver, gallbladder and pancreatic problems, and any repeated vomiting or feeling that food remains in the stomach for a long time. The history should also cover allergies, medullary thyroid carcinoma or MEN 2 in the family, retinopathy if you have diabetes, and pregnancy planning when relevant. This information helps determine whether treatment fits and what monitoring is needed [1, 2, 5].
The assessment may include weight, height, BMI, waist and blood pressure while exploring how weight affects health and movement. At La Rose Fifth Settlement, the nutrition consultation includes InBody, a body-contouring measurement, review of tests, medicines and medical history, followed by a plan suited to the case. Measurements can provide a baseline and show direction over time, but one reading is not a verdict on success, and a body-composition device does not replace examination or clinically indicated tests [5, 10, 13].
There is no single laboratory list required for everyone. Glucose or HbA1c, kidney or liver function, lipids or other tests may be selected when the history, symptoms or medicines raise a question. The point is for each test to answer a question and change a decision, not to order the largest package. Ask the clinician what would change with the result: starting, delaying, choosing another route or referring to another specialty [3, 5, 6].
The plan is more than an injection: food, muscle, symptoms and follow-up
Tirzepatide may reduce appetite, but that does not automatically improve food quality. A practical plan reviews meal pattern, protein sources, vegetables and fibre according to tolerance, and fluid, while managing nausea or constipation without severe restriction. It should also consider emotional eating, sleep and activity because medicine is one tool within long-term obesity care, not a replacement for habits and behavioural support [3, 7, 10].
Weight reduction can include both fat and lean mass. A SURMOUNT-1 substudy using DXA found group-level changes in both. That is a reason for follow-up to consider movement, strength, adequate intake and resistance activity suited to the individual rather than chasing scale weight alone. InBody can help follow a trend when repeated under similar conditions, but it is not the same as DXA and does not guarantee muscle preservation [10, 13].
Digestive effects such as nausea, diarrhoea, vomiting, constipation and abdominal pain are listed among common adverse effects. Agree a contact route before starting because continuing vomiting or poor fluid intake can cause dehydration and needs assessment. Trouble breathing, swelling of the face or tongue, or fainting requires immediate emergency care. Severe persistent abdominal pain, especially if it travels to the back, needs urgent assessment. Do not wait for Wednesday when symptoms are severe, and do not alter treatment yourself [1, 2, 14].
If loss is slow or stalls, what should be reviewed first?
One or two quiet weeks on the scale are not enough by themselves to declare treatment a failure. The clinician reviews the measurement trend over an appropriate period, use as prescribed, symptoms, food quantity and quality, fluid, activity and sleep, as well as medicines or health conditions that can affect weight. The automatic answer is not to intensify or switch treatment; the decision should reflect response, tolerability and the health goal [1, 5, 12].
Trial results are group averages, not a promise for one person. SURMOUNT-1 showed greater weight reduction with tirzepatide plus lifestyle intervention than placebo in the studied group, but response varied. If you want realistic timing and measurements, Mounjaro results and timeline explains expectations without promises. If the scale has stalled, Mounjaro not losing weight: reasons reviews use, eating, sleep, medicines and body composition without blame [3, 12].
A plan for continuing or stopping belongs at the beginning, not after the last pen. In SURMOUNT-4, withdrawing tirzepatide was associated with weight regain on average, while continuing maintained and added to weight reduction in the studied group. This does not mean every person must continue or predict your outcome, but it shows why maintenance needs food, activity, follow-up and a shared plan. Do not stop or restart treatment yourself [5, 11].
Wednesday clinic and online follow-up between visits
The Fifth Settlement service runs on Wednesday from 3:30 to 8 pm. An in-person visit suits the initial assessment, examination and measurements, and review of tests and medicines with Dr Shimaa Fouad. Once the plan is set, online follow-up can help in weeks when no examination or in-person measurement is needed: reviewing adherence, food and fluid, symptoms, glucose readings when relevant, and questions arising since the last visit [5, 10].
Remote follow-up is not a permanent substitute for examination. If symptoms change materially, or the clinician needs new measurements, a physical examination or tests, you will need an appropriate visit or coordination with another specialty. Before relying on online follow-up, agree what to send, when replies are expected, and when the appointment should become in person. The aim is follow-up with content and a decision, not simply a message about scale weight [4, 5].
For New Cairo residents, this rhythm means the assessment and measurements can happen at the Wednesday visit, with online follow-up when it is clinically sufficient between visits. A severe symptom still has a separate urgent route; a platform or WhatsApp is not an emergency service. Good organisation makes the plan sustainable without pretending everything can be solved remotely [5, 10, 14].
How to rank your New Cairo options and spot red flags
The first practical option is a clinic with a named physician and specialty, assessment before prescribing, clinical nutrition, measurements and clear follow-up. At La Rose Fifth Settlement, Dr Shimaa Fouad reviews medical history, tests and medicines, and the branch provides InBody, a body-contouring measurement and a plan for the case. The reason to consider it is a set of facts you can verify, not a claim that the clinic is “best” for everyone [4, 5, 10].
Another option may be a hospital-based obesity or medical-nutrition clinic when your case needs coordination with diabetes or internal medicine. A university-hospital outpatient clinic may fit complex cases involving several specialties. A bariatric surgical opinion is a separate route when a clinician finds referral criteria may apply. Mounjaro is not a guaranteed replacement for surgery, and surgery is not an automatic next step merely because loss is slow [3, 5].
Reviews and booking convenience help with logistics, but they are not enough to establish prescribing quality. Avoid guaranteed loss, prescriptions without a medical history, a secret protocol, injections without a clear name or source, or pressure to buy quickly. If medicine is prescribed and suitable, obtain it with a prescription from a licensed pharmacy. The FDA warns that unapproved products have not undergone the same review for safety, quality and effectiveness, and the Egyptian Drug Authority published an alert about potentially unknown-source Mounjaro packs and advised contacting the authority when a product is suspect [8, 9].
Routes from New Cairo and booking the Fifth Settlement branch
The address is CMC Medical Mall, fourth floor, North 90th Street, behind the Air Force Specialized Hospital, Fifth Settlement, New Cairo. Dr Shimaa Fouad attends on Wednesday from 3:30 to 8 pm. To book or ask about cost, call or send a WhatsApp message to 010 4066 1893, and the team will tell you the cost before you book. Schedules can change, so confirm the day and time when booking.
According to the recorded Google Maps measurements for the branch, Cairo Festival City is about 5.2 km and 10 minutes by car; El Yasmeen about 4.9–5.6 km and 9–10 minutes; Al Narges about 6.5 km and 12 minutes; El Banafseg about 6.9 km and 10 minutes; First Settlement about 7.4 km and 12 minutes; and Katameya Heights about 8 km and 12 minutes. These times are approximate and can change with traffic, so check the route when leaving.
Before the visit, bring your medicine and supplement list, recent tests and reports, and write down questions and symptoms. If you already use a product, bring its pack or a clear photograph showing the name, concentration and source. If you have trouble breathing, swelling of the face or tongue, fainting, severe persistent abdominal pain or vomiting that prevents fluid intake, do not wait for the appointment; seek emergency care [1, 2, 14]. For a stable concern and a complete assessment, Book at the Fifth Settlement branch [3, 5].
